Company · CIK 2035832
Aktis Oncology, Inc.
| CIK | 2035832 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | AKTS (Nasdaq) |
| First annual or quarterly report | 2026-03-30 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292283 | 2025-12-19 | 2026-01-09 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-09 | 424B4Final prospectus | 333-292283 | 0001193125-26-009078 |
| 2026-01-08 | EFFECTDeclared effective | 333-292283 | 9999999995-26-000113 |
| 2026-01-07 | S-1/AAmendment | 333-292283 | 0001193125-26-005437 |
| 2026-01-05 | S-1/AAmendment | 333-292283 | 0001193125-26-001466 |
| 2025-12-19 | S-1Registration filed | 333-292283 | 0001193125-25-326780 |
| 2024-10-11 | DRSDraft made public | 377-07497 | 0000950123-24-009664 |